Stratum Market Research
Request a sample

Healthcare & Life SciencesUnited StatesUpdated 4 Nov 2026

Alcoholic hepatitis treatment Market 2026: trade data and key figures

ClinicalTrials.gov lists 215 registered studies for alcoholic hepatitis. In the US, the core industry (Pharmaceutical preparation manufacturing) had 5,013 establishments in 2025. The EU counted 3,116 enterprises in the related industry class.

Edited by the Stratum Market Research editorial team. Updated 4 Nov 2026.

Headline figure

215registered studies

Registered clinical studies

PubMed papers per year mentioning alcoholic hepatitis20202025 U.S. National Library of Medicine, 4 Nov 2026

3,116 enterprises

The EU had 3,116 enterprises in NACE class C2120 (Manufacture of pharmaceutical preparations) in 2023.

Eurostat

428.65 EUR billion

EU enterprises in NACE class C2120 had net turnover of €428.65 billion in 2023.

Eurostat

600,730 persons employed

NACE class C2120 employed 600,730 people across the EU in 2023.

Eurostat
ChartPubMed papers per year mentioning alcoholic hepatitis
PubMed papers per year mentioning alcoholic hepatitis0501001502002020: 191 papers19120202021: 181 papers20212022: 164 papers20222023: 154 papers20232024: 111 papers20242025: 108 papers1082025

Source: U.S. National Library of Medicine (PubMed)

Why this market is moving now

  • US employment in the core industry shifted +8% since 2020.
  • Clinical research is active, with studies recruiting now.

What this market covers

Medicines and supportive care for liver inflammation caused by heavy alcohol use. Buyers are hospitals, liver specialists and transplant centres.

Typical segments

  • Corticosteroids
  • Anti-inflammatory biologics
  • Nutritional support
  • Liver transplant care

Who buys

  • Hospitals
  • Hepatologists
  • Transplant centres

Key figures

Each figure links to the page it came from.

FigureValueYearSource
The EU had 3,116 enterprises in NACE class C2120 (Manufacture of pharmaceutical preparations) in 2023.3,116 enterprises2023Eurostat
EU enterprises in NACE class C2120 had net turnover of €428.65 billion in 2023.428.65 EUR billion2023Eurostat
NACE class C2120 employed 600,730 people across the EU in 2023.600,730 persons employed2023Eurostat
The US had 5,013 private establishments in NAICS 325412 (Pharmaceutical preparation manufacturing) in 2025.5,013 establishments2025U.S. Bureau of Labor Statistics
NAICS 325412 employed an average of 229,922 people in US private industry in 2025.229,922 jobs2025U.S. Bureau of Labor Statistics
US employment in NAICS 325412 changed by +8% between 2020 (212,670 jobs) and 2025, calculated from BLS figures.+8 % change2025U.S. Bureau of Labor Statistics
Average annual pay in US NAICS 325412 was $158,377 in 2025.158,377 USD per year2025U.S. Bureau of Labor Statistics
ClinicalTrials.gov lists 215 registered studies for the condition "alcoholic hepatitis".215 registered studies2026U.S. National Library of Medicine (ClinicalTrials.gov)
28 of those studies were recruiting participants when checked in November 2026.28 recruiting studies2026U.S. National Library of Medicine (ClinicalTrials.gov)
PubMed indexed 108 papers mentioning "alcoholic hepatitis" in the title or abstract in 2025.108 papers2025U.S. National Library of Medicine (PubMed)

What the full report covers

Illustration of a report page with its five main parts numbered12345
  1. 1

    Executive summary

    The answer on two pages: size, growth and what drives it.

  2. 2

    Market size and outlook

    History, the current year and a five-year view with base, low and high cases.

  3. 3

    Segments and regions

    Splits by product, buyer and geography across the US, Europe and MEA.

  4. 4

    Company profiles

    The main players, how they compete and where they are investing.

  5. 5

    Data and method

    Every figure in Excel, with the sources and assumptions behind it.

  1. 01Executive summary
    The answer in one page: size, direction and what moves it
  2. 02Market definition and scope
    What is in and out of the United States market
  3. 03Market size, 2021 to 2025
    Historical series and growth rates
  4. 04Outlook to 2031
    Base, low and high scenarios with stated assumptions
  5. 05Rules, policy and deadlines
    Regulation and programmes that change demand
  6. 06Drivers and barriers
    What accelerates or slows adoption, by customer segment
  7. 07Prices, costs and margins
    Unit economics where public data allows
  8. 08Competitive landscape
    8 to 12 company profiles with recent moves
  9. 09Opportunities and risks
    For new entrants, suppliers and investors
  10. 10Method and sources
    Every assumption and source, listed

Included with the full report

  • PDF report, 40 to 60 pages
  • Excel data pack
  • Ready-to-use charts
  • Method note and assumptions
  • Written to order in 5 working days

Frequently asked questions

How many clinical trials study alcoholic hepatitis?

ClinicalTrials.gov lists 215 registered studies.

How many US companies are in the alcoholic hepatitis treatment industry?

BLS counts 5,013 private establishments in NAICS 325412 (Pharmaceutical preparation manufacturing), the closest official industry.

How many EU companies are in the alcoholic hepatitis treatment industry?

Eurostat counts 3,116 enterprises in NACE class C2120 (Manufacture of pharmaceutical preparations).

Sources and method

The figures on this page come from the public sources listed below. Read how we work.

  1. Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)sbs_ovw_act, geo EU27_2020, nace_r2 C2120, indic_sbs ENT_NR, 2023, 3116
  2. Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)sbs_ovw_act, geo EU27_2020, nace_r2 C2120, indic_sbs NETTUR_MEUR, 2023, 428651
  3. Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)sbs_ovw_act, geo EU27_2020, nace_r2 C2120, indic_sbs EMP_NR, 2023, 600730
  4. U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 325412, 2025 (2026-11-04)QCEW 2025 annual, US000, private, NAICS 325412, annual_avg_estabs 5013
  5. U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 325412, 2025 (2026-11-04)QCEW 2025 annual, US000, private, NAICS 325412, annual_avg_emplvl 229922
  6. U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 325412, 2025 (2026-11-04)QCEW 2020 annual_avg_emplvl 212670; 2025 annual_avg_emplvl 229922
  7. U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 325412, 2025 (2026-11-04)QCEW 2025 annual, US000, private, NAICS 325412, avg_annual_pay 158377
  8. U.S. National Library of Medicine (ClinicalTrials.gov): ClinicalTrials.gov API v2, condition "alcoholic hepatitis" (2026-11-04)query.cond=alcoholic hepatitis totalCount 215
  9. U.S. National Library of Medicine (ClinicalTrials.gov): ClinicalTrials.gov API v2, condition "alcoholic hepatitis", status recruiting (2026-11-04)filter.overallStatus=RECRUITING totalCount 28
  10. U.S. National Library of Medicine (PubMed): PubMed search "alcoholic hepatitis"[tiab] AND 2025[dp] (2026-11-04)esearch count 108

Free sample

Get a free sample of this report

We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.

  • Full table of contents
  • Two sample chapters
  • Method note and data outline
A market, a region or the decision you are making helps us pick the right chapters.

We use your details only to reply. See our privacy policy.

Full report $3,450Choose an edition